• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Start-up iBeat raises $1.5m in seed round for heart monitor watch

Start-up iBeat raises $1.5m in seed round for heart monitor watch

August 3, 2016 By Fink Densford

ibeat-1x1Early-stage heart monitor developer iBeat said yesterday it raised $1.5 million in an oversubscribed seed funding to support its heart-monitoring smartwatch.

The round was led by Maveron, Subtraction Capital and Correlation Ventures and joined by Band of Angels, industrial design firm Ammunition and other select individuals, the San Francisco, Calif.-based company said.

“The interest we’ve had in iBeat has been remarkable. We were oversubscribed for our seed funding and are thrilled to see such high caliber investors who also recognize the potential of this product. Cardiac arrest is the leading cause of death in the U.S., and 9 out of 10 people who have a cardiac arrest incident without intervention die. Our vision is to lower this number by bringing to market a beautiful and sleek smartwatch that will quicken the delivery of care and help save lives,” iBeat founder Ryan Howard said in a press release.

The company is building a “breakthrough” wearable that monitors and analyzes users heart activity around the clock. The smartwatch is designed to instantly alert the user or designated individuals in the event of an emergency, according to the company’s website.

“iBeat has the combination of a proven entrepreneur coupled with a massive consumer market that is primed for change. We’re incredibly excited about how their product can affect the lives of millions of people, and the potential to disrupt the multi-billion dollar PERS industry,” Maveron GP David Wu said in prepared remarks.

Funding from the round will support the recruiting of “high-profile talent,” to expand the company’s infrastructure and operations and to commercialize its heart-monitoring smartwatch.

“Ryan and the team he recruited from Practice Fusion had immense success building the largest patient physician platform in the U.S. iBeat is the kind of company we want to be part of — a visionary team bringing fresh ideas to an evolving technology that promises to save lives,” Band of Angels chair Ian Sobieski said in a prepared statement.

Filed Under: Business/Financial News, Cardiovascular, Patient Monitoring Tagged With: iBeat

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy